Pericellular cathepsin B and malignant progression

Cancer and Metastasis Reviews

Volumn 22, Issue 2-3, 2003, Pages 271-286

  Roshy, Stefanie ^a   Sloane, Bonnie F ^a,b   Moin, Kamiar ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell surface binding proteins; Cysteine proteases; Endosomes; Lysosomes; Secretion

Indexed keywords

CATHEPSIN B; CYSTEINE PROTEINASE; ENZYME PRECURSOR; LIPID; LIPOCORTIN 2; LYSOSOME ENZYME; MATRIX METALLOPROTEINASE; MEMBRANE ENZYME; MESSENGER RNA; SERINE PROTEINASE; SOMATOMEDIN B RECEPTOR; TETRAMER;

CANCER GROWTH; CAVEOLA; CELL ISOLATION; CELL SURFACE; CELL TRANSPORT; CELLULAR DISTRIBUTION; ENDOSOME; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INDUCTION; ENZYME METABOLISM; ENZYME REGULATION; ENZYME RELEASE; ENZYME STABILITY; ENZYME SYNTHESIS; GENE AMPLIFICATION; GENETIC STABILITY; HISTOPATHOLOGY; HUMAN; LYSOSOME; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; TISSUE DISTRIBUTION; TUMOR CELL; UPREGULATION;

ANIMALS; ANNEXIN A2; CATHEPSIN B; CELL MEMBRANE; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; HUMANS; NEOPLASMS;

EID: 0038215389     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023007717757     Document Type: Review

References (130)

1. Mort JS, Buttle DJ: Cathepsin B. Int J Biochem Cell Biol 29(5): 715-720, 1997
2. Rozhin J, Robinson D, Stevens MA, Lah TT, Honn KV, Ryan RE, Sloane BF: Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. Cancer Res 47(24 Pt 1): 6620-6628, 1987
3. Sameni M, Elliott E, Ziegler G, Fortgens PH, Dennison C, Sloane BF: Cathepsin B and D are localized at the surface of human breast cancer cells. Pathol Oncol Res 1(1): 43-53, 1995
4. Mach L, Stuwe K, Hagen A, Ballaun C, Glossl J: Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme. Biochem J 282(Pt 2): 577-582, 1992
5. Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, Domschke W, Lippert H, Peters C, Deussing J: Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 106(6): 773-781, 2000
6. Reinheckel T, Deussing J, Roth W, Peters C: Towards specific functions of lysosomal cysteine peptidases: Phenotypes of mice deficient for cathepsin B or cathepsin L. Biol Chem 382(5): 735-741, 2001
7. Barrett AJ, Kirschke H: Cathepsin B, Cathepsin H, Cathepsin L. Methods Enzymol 80(Pt C): 535-561, 1981
8. Lang A, Horler D, Baici A: The relative importance of cysteine peptidases in osteoarthritis. J Rheumatol 27(8): 1970-1979, 2000
9. Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J, Ziegler G: Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Sci 107(Pt 2): 373-384, 1994
10. Frosch BA, Berquin I, Emmert-Buck MR, Moin K, Sloane BF: Molecular regulation, membrane association and secretion of tumor cathepsin B. Apmis 107(1): 28-37, 1999
11. Baici A, Lang A, Horler D, Kissling R, Merlin C: Cathepsin B in osteoarthritis: Cytochemical and histochemical analysis of human femoral head cartilage. Ann Rheum Dis 54(4): 289-297, 1995
12. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF, Emmert-Buck MR: Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol 145(2): 301-309, 1994
13. Scorilas A, Fotiou S, Tsiambas E, Yotis J, Kotsiandri F, Sameni M, Sloane BF, Talieri M: Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biol Chem 383(7/8): 1297-1303, 2002
14. Sinha AA, Gleason DF, Deleon OF, Wilson MJ, Sloane BF: Localization of a biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat Rec 235(2): 233-240, 1993
15. Demchik LL, Sameni M, Nelson K, Mikkelsen T, Sloane BF: Cathepsin B and glioma invasion. Int J Dev Neurosci 17(5-6): 483-494, 1999
16. Koblinski JE, Dosescu J, Sameni M, Moin K, Clark K, Sloane BF: Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. J Biol Chem 277(35): 32220-32227, 2002
17. Yan S, Berquin IM, Troen BR, Sloane BF: Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma. DNA Cell Biol 19(2): 79-91, 2000
18. Naito S, Shimizu S, Matsuu M, Nakashima M, Nakayama T, Yamashita S, Sekine I: Ets-1 upregulates matrix metalloproteinase-1 expression through extracellular matrix adhesion in vascular endothelial cells. Biochem Biophys Res Commun 291(1): 130-138, 2002
19. Delannoy-Courdent A, Mattot V, Fafeur V, Fauquette W, Pollet I, Calmels T, Vercamer C, Boilly B, Vandenbunder B, Desbiens X: The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J Cell Sci 111(Pt 11): 1521-1534, 1998
20. Liu W, Wang G, Yakovlev AG: Identification and functional analysis of the rat caspase-3 gene promoter. J Biol Chem 277(10): 8273-8278, 2002
21. Guo M, Mathieu PA, Linebaugh B, Sloane BF, Reiners JJ Jr: Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-beta. A process initiated by the exocytosis of cathepsin B. J Biol Chem 277(17): 14829-14837, 2002
22. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M, Jaattela M: Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 153(5): 999-1010, 2001
23. Krepela E, Vicar J, Cernoch M: Cathepsin B in human breast tumor tissue and cancer cells. Neoplasma 36(1): 41-52, 1989
24. Lah TT, Calaf G, Kalman E, Shinde BG, Russo J, Jarosz D, Zabrecky J, Somers R, Daskal I: Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC). Biol Chem Hoppe Seyler 376(6): 357-363, 1995
25. Murnane MJ, Sheahan K, Ozdemirli M, Shuja S: Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res 51(4): 1137-1142, 1991
26. Emmert-Buck MR, Roth MJ, Zhuang Z, Campo E, Rozhin J, Sloane BF, Liotta LA, Stetler-Stevenson WG: Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 145(6): 1285-1290, 1994
27. Sheahan K, Shuja S, Murnane MJ: Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res 49(14): 3809-3814, 1989
28. Shuja S, Sheahan K, Murnane MJ: Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int J Cancer 49(3): 341-346, 1991
29. Hazen LG, Bleeker FE, Lauritzen B, Bahns S, Song J, Jonker A, Van Driel BE, Lyon H, Hansen U, Kohler A, Van Noorden CJ: Comparative localization of cathepsin B protein and activity in colorectal cancer. J Histochem Cytochem 48(10): 1421-1430, 2000
30. Hughes SJ, Glover TW, Zhu XX, Kuick R, Thoraval D, Orringer MB, Beer DG, Hanash S: A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc Natl Acad Sci USA 95(21): 12410-12415, 1998
31. Liu Y, Xiao S, Shi Y, Wang L, Ren W, Sloane BF: Cathepsin B on invasion and metastasis of gastric carcinoma. Chin Med J (Engl) 111(9): 784-788, 1998
32. Ebert W, Knoch H, Werle B, Trefz G, Muley T, Spiess E: Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res 14(3A): 895-899, 1994
33. Kusunoki T, Nishida S, Nakano T, Funasaka K, Kimoto S, Murata K, Tomura T: Study on cathepsin B activity in human thyroid tumors. Auris Nasus Larynx 22(1): 43-48, 1995
34. Rempel SA, Rosenblum ML, Mikkelsen T, Yan PS, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Ziegler G, Sloane BF: Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 54(23): 6027-6031, 1994
35. Sivaparvathi M, Sawaya R, Wang SW, Rayford A, Yamamoto M, Liotta LA, Nicolson GL, Rao JS: Over-expression and localization of cathepsin B during the progression of human gliomas. Clin Exp Metastasis 13(1): 49-56, 1995
36. Frohlich E, Schlagenhauff B, Mohrle M, Weber E, Klessen C, Rassner G: Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer 91(5): 972-982, 2001
37. Kim K, Cai J, Shuja S, Kuo T, Murnane MJ: Presence of activated ras correlates with increased cysteine proteinase activities in human colorectal carcinomas. Int J Cancer 79(4): 324-333, 1998
38. Abdollahi A, Getts LA, Sonoda G, Miller PD, Taguchi T, Godwin AK, Testa JR, Hamilton TC: Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cells. J Soc Gynecol Investig 6(1): 32-40, 1999
39. Berquin IM, Cao L, Fong D, Sloane BF: Identification of two new exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-encoding gene. Gene 159(2): 143-149, 1995
40. Wasylyk C, Wasylyk B: Oncogenic conversion alters the transcriptional properties of ets. Cell Growth Differ 3(9): 617-625, 1992
41. Fafeur V, Tulasne D, Queva C, Vercamer C, Dimster V, Mattot V, Stehelin D, Desbiens X, Vandenbunder B: The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells. Cell Growth Differ 8(6): 655-665, 1997
42. Mehtani S, Gong Q, Panella J, Subbiah S, Peffley DM, Frankfater A: In vivo expression of an alternatively spliced human tumor message that encodes a truncated form of cathepsin B. Subcellular distribution of the truncated enzyme in COS cells. J Biol Chem 273(21): 13236-13244, 1998
43. Berardi S, Lang A, Kostoulas G, Horler D, Vilei EM, Baici A: Alternative messenger RNA splicing and enzyme forms of cathepsin B in human osteoarthritic cartilage and cultured chondrocytes. Arthritis Rheum 44(8): 1819-1831, 2001
44. Berquin IM, Yan S, Katiyar K, Huang L, Sloane BF, Troen BR: Differentiating agents regulate cathepsin B gene expression in HL-60 cells. J Leukoc Biol 66(4): 609-616, 1999
45. Yan Z, Deng X, Chen M, Xu Y, Ahram M, Sloane BF, Friedman E: Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells. J Biol Chem 272(44): 27902-27907, 1997
46. Rozhin J, Sameni M, Ziegler G, Sloane BF: Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 54(24): 6517-6525, 1994
47. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61(5): 759-767, 1990
48. Marten K, Bremer C, Khazaie K, Sameni M, Sloane B, Tung CH, Weissleder R: Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology 122(2): 406-414, 2002
49. Hartz PA, Wilson PD: Functional defects in lysosomal enzymes in autosomal dominant polycystic kidney disease (ADPKD): Abnormalities in synthesis, molecular processing, polarity, and secretion. Biochem Mol Med 60(1): 8-26, 1997
50. Wilson PD, Du J, Norman JT: Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur J Cell Biol 61(1): 131-138, 1993
51. Du J, Wilson PD: Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 269(2 Pt 1): C487-C495, 1995
52. Wilson PD, Burrow CR: Autosomal dominant polycystic kidney disease: Cellular and molecular mechanisms of cyst formation. Adv Nephrol Necker Hosp 21: 125-142, 1992
53. Carone FA, Nakamura S, Schumacher BS, Punyarit P, Bauer KD: Cyst-derived cells do not exhibit accelerated growth or features of transformed cells in vitro. Kidney Int 35(6): 1351-1357, 1989
54. Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H: Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res 49(14): 3904-3909, 1989
55. Matteoni R, Kreis TE: Translocation and clustering of endosomes and lysosomes depends on microtubules. J Cell Biol 105(3): 1253-1265, 1987
56. Nishimura Y, Sameni M, Sloane BF: Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells. Pathol Oncol Res 4(4): 283-296, 1998
57. Milisav I: Dynein and dynein-related genes. Cell Motil Cytoskeleton 39(4): 261-272, 1998
58. Harada A, Takei Y, Kanai Y, Tanaka Y, Nonaka S, Hirokawa N: Golgi vesiculation and lysosome dispersion in cells lacking cytoplasmic dynein. J Cell Biol 141(1): 51-59, 1998
59. Quintyne NJ, Gill SR, Eckley DM, Crego CL, Compton DA, Schroer TA: Dynactin is required for microtubule anchoring at centrosomes. J Cell Biol 147(2): 321-334, 1999
60. Bi GQ, Morris RL, Liao G, Alderton JM, Scholey JM, Steinhardt RA: Kinesin- and myosin-driven steps of vesicle recruitment for Ca2+-regulated exocytosis. J Cell Biol 138(5): 999-1008, 1997
61. Kamal A, Goldstein LS: Principles of cargo attachment to cytoplasmic motor proteins. Curr Opin Cell Biol 14(1): 63-68, 2002
62. Nakata T, Hirokawa N: Point mutation of adenosine triphosphate-binding motif generated rigor kinesin that selectively blocks anterograde lysosome membrane transport. J Cell Biol 131(4): 1039-1053, 1995
63. Stearns ME, Wang M: Regulation of kinesin expression and type IV collagenase secretion in invasive human prostate PC-3 tumor sublines. Cancer Res 51(21): 5866-5875, 1991
64. Santama N, Krijnse-Locker J, Griffiths G, Noda Y, Hirokawa N, Dotti CG: KIF2beta, a new kinesin super-family protein in non-neuronal cells, is associated with lysosomes and may be implicated in their centrifugal translocation. Embo J 17(20): 5855-5867, 1998
65. Montcourrier P, Mangeat PH, Salazar G, Morisset M, Sahuquet A, Rochefort H: Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res 50(18): 6045-6054, 1990
66. Ludwig T, Ovitt CE, Bauer U, Hollinshead M, Remmler J, Lobel P, Ruther U, Hoflack B: Targeted disruption of the mouse cation-dependent mannose 6-phosphate receptor results in partial missorting of multiple lysosomal enzymes. Embo J 12(13): 5225-5235, 1993
67. Braulke T, Mach L, Hoflack B, Glossl J: Biosynthesis and endocytosis of lysosomal enzymes in human colon carcinoma SW 1116 cells: Impaired internalization of plasma membrane-associated cation-independent mannose 6-phosphate receptor. Arch Biochem Biophys 298(1): 176-181, 1992
68. Kuliawat R, Klumperman J, Ludwig T, Arvan P: Differential sorting of lysosomal enzymes out of the regulated secretory pathway in pancreatic beta-cells. J Cell Biol 137(3): 595-608, 1997
69. Lorenzo K, Ton P, Clark JL, Coulibaly S, Mach L: Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor. Cancer Res 60(15): 4070-4076, 2000
70. Kuliawat R, Arvan P: Distinct molecular mechanisms for protein sorting within immature secretory granules of pancreatic beta-cells. J Cell Biol 126(1): 77-86, 1994
71. De Stefanis D, Demoz M, Dragonetti A, Houri JJ, Ogier-Denis E, Codogno P, Baccino FM, Isidoro C: Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line. Cell Tissue Res 289(1): 109-117, 1997
72. Laurent-Matha V, Farnoud MR, Lucas A, Rougeot C, Garcia M, Rochefort H: Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors. J Cell Sci 111(Pt 17): 2539-2549, 1998
73. McIntyre GF, Erickson AH: Procathepsins L and D are membrane-bound in acidic microsomal vesicles. J Biol Chem 266(23): 15438-15445, 1991
74. McIntyre GF, Erickson AH: The lysosomal proenzyme receptor that binds procathepsin L to microsomal membranes at pH 5 is a 43-kDa integral membrane protein. Proc Natl Acad Sci USA 90(22): 10588-10592, 1993
75. McIntyre GF, Godbold GD, Erickson AH: The pH-dependent membrane association of procathepsin L is mediated by a 9-residue sequence within the propeptide. J Biol Chem 269(1): 567-572, 1994
76. Ahn K, Yeyeodu S, Collette J, Madden V, Arthur J, Li L, Erickson AH: An alternate targeting pathway for procathepsin L in mouse fibroblasts. Traffic 3(2): 147-159, 2002
77. Linebaugh BE, Sameni M, Day NA, Sloane BF, Keppler D: Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur J Biochem 264(1): 100-109, 1999
78. Turner MD, Arvan P: Protein traffic from the secretory pathway to the endosomal system in pancreatic beta-cells. J Biol Chem 275(19): 14025-14030, 2000
79. Heuser J: Changes in lysosome shape and distribution correlated with changes in cytoplasmic pH. J Cell Biol 108(3): 855-864, 1989
80. Rodriguez A, Samoff E, Rioult MG, Chung A, Andrews NW: Host cell invasion by trypanosomes requires lysosomes and microtubule/kinesin-mediated transport. J Cell Biol 134(2): 349-362, 1996
81. Tardieux I, Webster P, Ravesloot J, Boron W, Lunn JA, Heuser JE, Andrews NW: Lysosome recruitment and fusion are early events required for trypanosome invasion of mammalian cells. Cell 71(7): 1117-1130, 1992
82. Gerasimenko JV, Gerasimenko OV, Petersen OH: Membrane repair: Ca(2 +)-elicited lysosomal exocytosis. Curr Biol 11(23): R971-R974, 2001
83. Ulbricht B, Henny H, Horstmann H, Spring H, Faigle W, Spiess E: Influence of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) on the localization of cathepsin B and cathepsin L in human lung tumor cells. Eur J Cell Biol 74(3): 294-301, 1997
84. Lemaire R, Huet G, Zerimech F, Grard G, Fontaine C, Duquesnoy B, Flipo RM: Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br J Rheumatol 36(7): 735-743, 1997
85. Balaji KN, Schaschke N, Machleidt W, Catalfamo M, Henkart PA: Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J Exp Med 196(4): 493-503, 2002
86. Brix K, Lemansky P, Herzog V: Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. Endocrinology 137(5): 1963-1974, 1996
87. Linke M, Jordans S, Mach L, Herzog V, Brix K: Thyroid stimulating hormone upregulates secretion of cathepsin B from thyroid epithelial cells. Biol Chem 383(5): 773-784, 2002
88. Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV: Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci USA 83(8): 2483-2487, 1986
89. Warwas M, Haczynska H, Gerber J, Nowak M: Cathepsin B-like activity as a serum tumor marker in ovarian carcinoma. Eur J Clin Chem Clin Biochem 35(4): 301-304, 1997
90. Sinha AA, Jamuar MP, Wilson MJ, Rozhin J, Sloane BF: Plasma membrane association of cathepsin B in human prostate cancer: Biochemical and immunogold electron microscopic analysis. Prostate 49(3): 172-184, 2001
91. Cao L, Taggart RT, Berquin IM, Moin K, Fong D, Sloane BF: Human gastric adenocarcinoma cathepsin B: Isolation and sequencing of full-length cDNAs and polymorphisms of the gene. Gene 139(2): 163-169, 1994
92. Moin K, Day NA, Sameni M, Hasnain S, Hirama T, Sloane BF: Human tumor cathepsin B. Comparison with normal liver cathepsin B. Biochem J 285(Pt 2): 427-434, 1992
93. Moin K, Cao L, Day NA, Koblinski JE, Sloane BF: Tumor cell membrane cathepsin B. Biol Chem 379(8-9): 1093-1099, 1998
94. Almeida PC, Nantes IL, Chagas JR, Rizzi CC, Faljoni-Alario A, Carmona E, Juliano L, Nader HB, Tersariol IL: Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation. J Biol Chem 276(2): 944-951, 2001
95. Arkona C, Wiederanders B: Expression, subcellular distribution and plasma membrane binding of cathepsin B and gelatinases in bone metastatic tissue. Biol Chem 377(11): 695-702, 1996
96. Mai J, Finley RL Jr, Waisman DM, Sloane BF: Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J Biol Chem 275(17): 12806-12812, 2000
97. Schafer BW, Heizmann CW: The S100 family of EF-hand calcium-binding proteins: Functions and pathology. Trends Biochem Sci 21(4): 134-140, 1996
98. Thiel C, Osborn M, Gerke V: The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca(2+)-binding sites. J Cell Sci 103(Pt 3): 733-742, 1992
99. Vishwanatha JK, Chiang Y, Kumble KD, Hollingsworth MA, Pour PM: Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 14(12): 2575-2579, 1993
100. Kumble KD, Hirota M, Pour PM, Vishwanatha JK: Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. Cancer Res 52(1): 163-167, 1992
101. Cole SP, Pinkoski MJ, Bhardwaj G, Deeley RG: Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br J Cancer 65(4): 498-502, 1992
102. Reeves SA, Chavez-Kappel C, Davis R, Rosenblum M, Israel MA: Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. Cancer Res 52(24): 6871-6876, 1992
103. Roseman BJ, Bollen A, Hsu J, Lamborn K, Israel MA: Annexin II marks astrocytic brain tumors of high histologic grade. Oncol Res 6(12): 561-567, 1994
104. Chiang Y, Davis RG, Vishwanatha JK: Altered expression of annexin II in human B-cell lymphoma cell lines. Biochim Biophys Acta 1313(3): 295-301, 1996
105. Yeatman TJ, Updyke TV, Kaetzel MA, Dedman JR, Nicolson GL: Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin Exp Metastasis 11(1): 37-44, 1993
106. Kassam G, Manro A, Braat CE, Louie P, Fitzpatrick SL, Waisman DM: Characterization of the heparin binding properties of annexin II tetramer. J Biol Chem 272(24): 15093-15100, 1997
107. Wirl G, Schwartz-Albiez R: Collagen-binding proteins of mammary epithelial cells are related to Ca2(+)- and phospholipid-binding annexins. J Cell Physiol 144(3): 511-522, 1990
108. Chung CY, Erickson HP: Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 126(2): 539-548, 1994
109. Kassam G, Choi KS, Ghuman J, Kang HM, Fitzpatrick SL, Zackson T, Zackson S, Toba M, Shinomiya A, Waisman DM: The role of annexin II tetramer in the activation of plasminogen. J Biol Chem 273(8): 4790-4799, 1998
110. Hajjar KA, Jacovina AT, Chacko J: An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin 11. J Biol Chem 269(33): 21191-21197, 1994
111. Sargiacomo M, Sudol M, Tang Z, Lisanti MP: Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122(4): 789-807, 1993
112. Harder T, Gerke V: The annexin 112p11(2) complex is the major protein component of the triton X-100-insoluble low-density fraction prepared from MDCK cells in the presence of Ca2+. Biochim Biophys Acta 1223(3): 375-382, 1994
113. Lipardi C, Mora R, Colomer V, Paladino S, Nitsch L, Rodriguez-Boulan E, Zurzolo C: Caveolin transfection results in caveolae formation but not apical sorting of glycosylphosphatidylinositol (GPI)-anchored proteins in epithelial cells. J Cell Biol 140(3): 617-626, 1998
114. Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC, Mellon JK: Caveolin-1 expression is associated with high-grade bladder cancer. Urology 58(5): 811-814, 2001
115. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT, Thompson TC: Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 4(8): 1873-1880, 1998
116. Fine SW, Lisanti MP, Galbiati F, Li M: Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Patho1 115(5): 719-724, 2001
117. Yang G, Truong LD, Wheeler TM, Thompson TC: Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker. Cancer Res 59(22): 5719-5723, 1999
118. Stahl A, Mueller BM: The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol 129(2): 335-344, 1995
119. Annabi B, Lachambre M, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R: Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains. Biochem J 353(Pt 3): 547-553, 2001
120. Puyraimond A, Fridman R, Lemesle M, Arbeille B, Menashi S: MMP-2 colocalizes with caveolae on the surface of endothelial cellsl Exp Cell Res 262(1): 28-36, 2001
121. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF: Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumor tissues. Biochem J 282(Pt 1): 273-278, 1992
122. Visscher DW, Sloane BF, Sameni M, Babiarz JW, Jacobson J, Crissman JD: Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia. Mod Pathol 7(1): 76-81, 1994
123. Khan A, Krishna M, Baker SP, Malhothra R, Banner BF: Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer. Arch Pathol Lab Med 122(2): 172-177, 1998
124. Sukoh N, Abe S, Ogura S, Isobe H, Takekawa H, Inoue K, Kawakami Y: Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer 74(1): 46-51, 1994
125. Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R: Cathepsin B expression in tumor cells and laminin distribution in pulmonary adenocarcinoma. J Clin Pathol 46(1): 18-22, 1993
126. Sameni M, Dosescu J, Sloane BF: Imaging proteolysis by living human glioma cells. Biol Chem 382(5): 785-788, 2001
127. Sameni M, Moin K, Sloane BF: Imaging proteolysis by living human breast cancer cells. Neoplasia 2(6): 496-504, 2000
128. Mai J, Waisman DM, Sloane BF: Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta 1477(1-2): 215-230, 2000
129. Gong Q, Chan SJ, Bajkowski AS, Steiner DF, Frankfater A: Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA. DNA Cell Biol 12(4): 299-309, 1993
130. Felbor U, Kessler B,Mothes W, Goebel HH, Ploegh HL., Bronson RT, Olsen BR: Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci USA 99(12): 7883-7888, 2002